These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11302871)

  • 1. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma).
    Matucci-Cerinic M; Giacomelli R; Pignone A; Cagnoni ML; Generini S; Casale R; Cipriani P; Del Rosso A; Tirassa P; Konttinen YT; Kahaleh BM; Fan PS; Paoletti M; Marchesi C; Cagnoni M; Aloe L
    Ann Rheum Dis; 2001 May; 60(5):487-94. PubMed ID: 11302871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.
    Pignone A; Scaletti C; Matucci-Cerinic M; Vázquez-Abad D; Meroni PL; Del Papa N; Falcini F; Generini S; Rothfield N; Cagnoni M
    Clin Exp Rheumatol; 1998; 16(5):527-32. PubMed ID: 9779298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
    Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
    Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria.
    Başak PY; Vural H; Kazanoglu OO; Erturan I; Buyukbayram HI
    Int J Dermatol; 2014 Dec; 53(12):1526-30. PubMed ID: 25209952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neurotrophin profile in systemic sclerosis.
    Lise MC; Sparsa A; Marie I; Lalloué F; Ly K; Martel C; Bezanahary H; Gondran G; Loustaud-Ratti V; Bonnetblanc JM; Vidal E; Jauberteau MO; Fauchais AL
    PLoS One; 2010 Nov; 5(11):e13918. PubMed ID: 21085492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide variability in man.
    Onuoha GN; Nugent AM; Hunter SJ; Alpar EK; McEneaney DJ; Campbell NP; Shaw C; Buchanan KD; Nicholls DP
    Eur J Clin Invest; 2000 Jul; 30(7):570-7. PubMed ID: 10886296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
    Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases.
    El-Sayed ZA; Mostafa GA; Aly GS; El-Shahed GS; El-Aziz MM; El-Emam SM
    Rheumatology (Oxford); 2009 Jul; 48(7):843-8. PubMed ID: 19465591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
    Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
    Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
    Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
    Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suckling reduces allergic skin responses and plasma levels of neuropeptide and neurotrophin in lactating women with atopic eczema/dermatitis syndrome.
    Kimata H
    Int Arch Allergy Immunol; 2003 Dec; 132(4):380-3. PubMed ID: 14707470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis.
    Hodeib A; El-Samad ZA; Hanafy H; El-Latief AA; El-Bendary A; Abu-Raya A
    Indian J Dermatol; 2010; 55(2):135-9. PubMed ID: 20606880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
    Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
    Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.